Migdal Insurance & Financial Holdings Ltd. Sangamo Therapeutics, Inc Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$10.17 - $12.64 $699,451 - $869,328	-68,776 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$10.88 - $17.05 $464,358 - $727,694	42,680 Added 163.55%	68,776 $862,000
Q4 2020 Feb 08, 2021	BUY	$9.23 - $18.18 $240,866 - $474,425	26,096 New	26,096 $407,000

Others Institutions Holding SGMO

# of Institutions

115

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$48.6 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$24 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$12.1 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$11.8 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$5.88 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $391M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account